Follow
Ann Daly
Ann Daly
Professor of Pharmacogenetics, Newcastle University
Verified email at ncl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
P Kuehl, J Zhang, Y Lin, J Lamba, M Assem, J Schuetz, PB Watkins, ...
Nature genetics 27 (4), 383-391, 2001
27122001
Estimation of the warfarin dose with clinical and pharmacogenetic data
International Warfarin Pharmacogenetics Consortium
New England Journal of Medicine 360 (8), 753-764, 2009
18472009
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
GP Aithal, CP Day, PJL Kesteven, AK Daly
The Lancet 353 (9154), 717-719, 1999
17021999
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen
EA Sconce, TI Khan, HA Wynne, P Avery, L Monkhouse, BP King, P Wood, ...
Blood 106 (7), 2329-2333, 2005
12482005
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
AK Daly, PT Donaldson, P Bhatnagar, Y Shen, I Pe'er, A Floratos, MJ Daly, ...
Nature genetics 41 (7), 816-819, 2009
11842009
Case definition and phenotype standardization in drug‐induced liver injury
GP Aithal, PB Watkins, RJ Andrade, D Larrey, M Molokhia, H Takikawa, ...
Clinical Pharmacology & Therapeutics 89 (6), 806-815, 2011
11632011
Metabolic gene polymorphism frequencies in control populations
S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ...
Cancer Epidemiology Biomarkers & Prevention 10 (12), 1239-1248, 2001
11382001
A randomized trial of genotype-guided dosing of warfarin
M Pirmohamed, G Burnside, N Eriksson, AL Jorgensen, CH Toh, ...
New England Journal of Medicine 369 (24), 2294-2303, 2013
9622013
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
D Pfister, NG Nez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ...
Nature 592 (7854), 450-456, 2021
8422021
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
YL Liu, HL Reeves, AD Burt, D Tiniakos, S McPherson, JBS Leathart, ...
Nature communications 5 (1), 4309, 2014
7042014
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
7012010
Nomenclature for human CYP2D6 alleles
AK Daly, J Brockmoller, F Broly, M Eichelbaum, WE Evans, FJ Gonzalez, ...
Pharmacogenetics and Genomics 6 (3), 193-201, 1996
6041996
Carriage of the PNPLA3 rs738409 C> G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
YL Liu, GL Patman, JBS Leathart, AC Piguet, AD Burt, JF Dufour, CP Day, ...
Journal of hepatology 61 (1), 75-81, 2014
5762014
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles
MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ...
Gastroenterology 141 (1), 338-347, 2011
5062011
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi, JT Backman, LI Kajosaari, JB Leathart, M Neuvonen, AK Daly, ...
Clinical Pharmacology & Therapeutics 77 (6), 468-478, 2005
4342005
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
JK Lamba, YS Lin, K Thummel, A Daly, PB Watkins, S Strom, J Zhang, ...
Pharmacogenetics and Genomics 12 (2), 121-132, 2002
4032002
Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes
AK Daly, GP Aithal, JBS Leathart, RA Swainsbury, TS Dang, CP Day
Gastroenterology 132 (1), 272-281, 2007
3982007
Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis
J Grove, AK Daly, MF Bassendine, CP Day
Hepatology 26 (1), 143-146, 1997
3891997
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants
J Zhang, P Kuehl, ED Green, JW Touchman, PB Watkins, A Daly, SD Hall, ...
Pharmacogenetics and genomics 11 (7), 555-572, 2001
3832001
The role of individual human cytochrpmes P450 in drug metabolism and clinical response
S Cholerton, AK Daly, JR Idle
Trends in pharmacological sciences 13, 434-439, 1992
3771992
The system can't perform the operation now. Try again later.
Articles 1–20